Abstract

Store-operated Ca 2+ influx (SOC) is a major Ca 2+ entry pathway in vascular endothelial cells, thus contributing to the regulation of endothelial barrier function, nitric oxide production, and angiogenesis. The basic molecular mechanisms underlying SOC have recently been elucidated. Namely, STIM1 serves as a store site Ca 2+ sensor and thereby activates SOC channels. However, the mechanisms regulating SOC remains largely unknown. STIM1 has been previously reported to be a phosphoprotein with unknown function. The present study thus investigated the role of STIM1 phosphorylation in the regulation of SOC. STIM1 phosphorylation was evaluated with a new SDS-PAGE technique utilizing a Phos-tag TM compound, which specifically binds to a phosphate group, thus allowing the separation of phosphoproteins from the unphosphorylated form. Thapsigargin, an inhibitor of endoplasmic reticulum Ca 2+ pump, induced a depletion of the Ca 2+ stores in porcine aortic endothelial cells (PAEC) and HeLa cells in the absence of extracellular Ca 2+ . The following repletion of the external Ca 2+ induced a sustained Ca 2+ influx. STIM1 knockdown abolished this influx. Thapsigargin induced >95% phosphorylation of STIM1 in the absence of extracellular Ca 2+ , which persisted irreversibly even after the repletion of external Ca 2+ . Thrombin induced Ca 2+ depletion and subsequent activation of SOC in PAEC, at a lower level than that seen with thapsigargin. Thrombin also induced a lower level of STIM1 phosphorylation in PAEC. However, it returned to the pre-stimulation level after Ca 2+ repletion. Myosin light chain kinase inhibitors, ML-9 and wortmannin, inhibited thapsigargin-induced STIM1 phosphorylation, while Rho kinase inhibitors, Y27632 and H1152, or PKC inhibitor GF109203X had no effect. The effect of the kinase inhibitors were correlated with the effect on the sustained phase of SOC. Analysis of various STIM1 deletion mutants revealed that the C-terminal region is the site of phosphorylation. These results provide the first evidence that STIM1 is phosphorylated following depletion of Ca 2+ stores and this phosphorylation contributes to the maintenance of Ca 2+ influx via SOC. STIM1 phosphorylation may provide a new therapeutic target to maintain normal endothelial functions.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.